医学
随机对照试验
荟萃分析
牙科
临床试验
置信区间
子群分析
纳入和排除标准
梅德林
牙体牙髓科
相对风险
外科
内科学
病理
替代医学
政治学
法学
作者
Sidhartha Sharma,Divya Nangia,Aakriti Saini,Vijay Kumar,Amrita Chawla,Perumal Vanamail,Ajay Logani
标识
DOI:10.4103/jcd.jcd_535_21
摘要
Background: Regenerative endodontic procedures (REP) have the advantage of restoring root canal's native defense ability by re-establishing vital pulp-like tissue. This review aims to determine the overall clinical and/or radiographic success rate (O) of REP (I) in mature permanent teeth (P) and to compare it (C) with nonsurgical endodontic treatment (NSET).
Materials and Methods: Sources: PubMed, Web of Science, Embase, EBSCO, Cochrane Central Register of Controlled trials, ClinicalTrials.gov, Clinical Trials Registry-India and OpenGrey. Inclusion: Randomized clinical trials and single-arm prospective studies evaluating the treatment outcomes of REP in mature permanent teeth. Exclusion: Incomplete trials/studies, in vitro studies, animal studies, case reports/series, conference proceedings. Cochrane ROB2.0 and ROBINS-I tools were used to assess the risk of bias. Risk difference (R.D.) between NSET and REP was determined by meta-analysis of the randomized clinical trials. The overall success rate of REP was calculated using data from both randomized clinical trials and single-arm prospective studies. Sensitivity analysis and subgroup analysis were performed.
Results: Ten studies (n = 552) were included. R.D between REP and NSET was 0.032 (95% C.I: 0.023–0.087; P = 0.258). Overall success rate of REP was 96.0% (95% confidence interval: 94%–98%). No significant difference was found in sensitivity analysis (P = 0.551), or any of the subgroup analysis (P > 0.05).
Discussion: A limited number of randomized clinical trials were available, and only two of them had a low risk of bias. Consistent results were obtained in both types of included studies.
Conclusion: Based on a limited number of comparative studies, REP has a similar success rate to NSET in mature permanent teeth.
Other: Funding: Nil. Registration: PROSPERO (CRD42020204882).
科研通智能强力驱动
Strongly Powered by AbleSci AI